RCMI Coordinating Center (RCMI CC) Header Logo

Connection

J Goodwin to Anticoagulants

This is a "connection" page, showing publications J Goodwin has written about Anticoagulants.
Connection Strength

1.507
  1. Albaeni A, Li S, Shan Y, Thakker R, Gaalema DE, Saxena R, Kuo YF, Jneid H, Goodwin J. Outcomes Associated With Novel Oral Anticoagulants and Warfarin in Patients With Cardiac Thrombus Following ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2025 Feb 01; 236:72-78.
    View in: PubMed
    Score: 0.829
  2. Raji MA, Lowery M, Lin YL, Kuo YF, Baillargeon J, Goodwin JS. National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries. Ann Pharmacother. 2013 Jan; 47(1):35-42.
    View in: PubMed
    Score: 0.365
  3. Holmes HM, Bain KT, Zalpour A, Luo R, Bruera E, Goodwin JS. Predictors of anticoagulation in hospice patients with lung cancer. Cancer. 2010 Oct 15; 116(20):4817-24.
    View in: PubMed
    Score: 0.312
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support